Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer.
Citation: Methodist DeBakey cardiovascular journal. 19(1):15-19, 2023.PMID: 36742441Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: *Heart Failure | *Heart-Assist Devices | *Neoplasms | Feasibility Studies | Heart Failure/th [Therapy] | Humans | Retrospective StudiesYear: 2023ISSN:- 1947-6108
- https://orcid.org/0000-0001-9687-9475:
- Sheikh, Farooq H
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | Available |
The HeartMate 3 left ventricular assist device possesses the unique feature of having its electronics and software located within the housing of the pump, which may predispose it to malfunction from radiation exposure during cancer treatment. We investigated this association in a case series of two patients at our institution. Copyright: © 2023 The Author(s).
English